Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 107 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1061 11.0 months NSCLC 4 Biologic therapy
Chemotherapy
San Filippo Neri Hospital Italy 5/2005
Treatment Details: Patients: This Phase II study involved 58 patients with non-small cell lung cancer. Forty-four patients were men, fourteen were women, and the median age was 60. Over 50% of the patients h
 
1062 11.0 months Advanced NSCLC 4 Chemotherapy
S. Orsola-Malpighi Hospital Italy 1/2005
Treatment Details: Patients: This Phase III study involved 272 patients with advanced non-small cell lung cancer. 214 patients were men, and 58 were women. The median age was 63 years. The patients were ran
 
1063 11.0 months Advanced NSCLC 4 Chemotherapy
S. Orsola-Malpighi Hospital Italy 1/2005
Treatment Details: Patients: This Phase III study involved 272 patients with advanced non-small cell lung cancer. 214 patients were men, and 58 were women. The median age was 63 years. The patients were ran
 
1064 11.0 months Advanced NSCLC 5 Biologic therapy
Chemotherapy
Hospital Grosshansdorf Germany 4/2007
Treatment Details: Patients: This phase III study enrolled 1,172 patients with advanced, unresectable, recurrent or metastatic non-small-cell lung cancer. Approximately 25% were women and 75% were men. The
 
1065 11.0 months Recurrent ovarian cancer or primary peritoneal and fallopian tube cancer 5 Biologic therapy
University of Chicago Medical Center United States 4/2008
Treatment Details: Patients: This phase II study involved thirteen women with ovarian or fallopian tube cancer. The cancer site in the majority (11) patients was the ovary. The median age was 56, ranging fr
 
1066 11.0 months Stage IV NSCLC 4 Chemotherapy
Memorial Sloan-Kettering Cancer Center United States 2/2008
Treatment Details: Patients: This study involved 40 patients with stage IV non-small cell lung cancer. There were similar numbers of women (21) and men (19). Their median age was 70, ranging from 43-84 year
 
1067 11.0 months Advanced NSCLC 4 Chemotherapy
Medical University Hospital Austria 5/2006
Treatment Details: Patients: This Phase III trial involved a total of 352 patients with advanced non-small-cell lung cancer. There were 255 men and 97 women and the ages ranged from 29 to 77 (the median age w
 
1068 11.0 months metastatic melanoma 4 Chemotherapy
Immunotherapy
Istituto Nazionale per lo Studio e la Curra dei Tumori Italy 2/2006
Treatment Details: Patients: This phase III study involved 151 patients with metastatic melanoma. Patients were divided into two groups: Group A had 75 patients and Group B had 76 patients. The median age f
 
1069 11.0 months NSCLC 5 Chemotherapy
Immunotherapy
University Medical Center Mannheim Germany 4/2011
Treatment Details: Patients: This study involved non-small cell lung cancer patients that had not received prior chemotherapy. Patients were divided into 2 separate treatment groups. Group A consisted of 41
 
1070 11.0 months NSCLC 4 Chemotherapy
St. James’s University Hospital United Kingdom 4/2011
Treatment Details: Patients: This study involved patients with previously treated non-small cell lung cancer who were divided into two separate treatment groups. Group A consisted of 25 patients with a media
 
Page 107 of 187  | Previous Page  | Next Page